DAVID MARTINEZ: Open Payments
NPI 1063176303 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,124 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $289 · 2025 $1,124
Food & beverage: $1,124
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $338 |
| AKEBIA THERAPEUTICS INC | 2 | $217 |
| SANOFI-AVENTIS U.S. LLC | 1 | $121 |
| Phathom Pharmaceuticals, Inc. | 1 | $120 |
| Madrigal Pharmaceuticals | 1 | $119 |
| Ascensia Diabetes Care Us Inc. | 1 | $104 |
| Amgen Inc. | 1 | $71 |
| ABBVIE INC. | 1 | $34 |
Products named: Vafseo, ZEPBOUND, TZIELD, VOQUEZNA, REZDIFFRA, QULIPTA.
Industry payments across TX — which companies pay providers there.
